Amedeo's Top 20

Amedeo Smart

Independent Medical Education

19 December 2016

Multidisciplinary Journal Club

  1. Cloughesy T, Finocchiaro G, Belda-Iniesta C, Recht L, et al.
    Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-M
    J Clin Oncol 2016.

  1. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, et al.
    Ulcerative colitis.
    Lancet 2016.

  2. Li Y, Banerjee S, Wang Y, Goldstein SA, et al.
    Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.
    Proc Natl Acad Sci U S A 2016;113:2241-6.

  3. Bruix J, Qin S, Merle P, Granito A, et al.
    Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet 2016.

  4. Gross NJ, Barnes PJ.
    New Therapies for Asthma and COPD.
    Am J Respir Crit Care Med 2016.

  1. Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, et al.
    Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.
    Clin Infect Dis 2016.

  2. Cosman F, Nieves JW, Dempster D.
    Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis.
    J Bone Miner Res 2016.

  3. Rea D, Nicolini FE, Tulliez M, Guilhot F, et al.
    Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
    Blood 2016.

  4. Jain N, Roberts KG, Jabbour E, Patel K, et al.
    Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.
    Blood 2016.

  5. Engel J Jr.
    What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture.
    Neurology 2016;87:2483-2489.

  1. Teerlink JR, Felker GM, McMurray JJ, Solomon SD, et al.
    Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.
    Lancet 2016.

  2. Rotenstein LS, Ramos MA, Torre M, Segal JB, et al.
    Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students: A Systematic Review and Meta-Analysis.
    JAMA 2016;316:2214-2236.

  3. Tasian SK, Hurtz C, Wertheim GB, Bailey NG, et al.
    High incidence of philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) in older adults with B-ALL.
    Leukemia 2016.

  4. Voskoboinik A, Prabhu S, Ling LH, Kalman JM, et al.
    Alcohol and Atrial Fibrillation: A Sobering Review.
    J Am Coll Cardiol 2016;68:2567-2576.

  5. Reznik M, Kamel H, Gialdini G, Pandya A, et al.
    Timing of Carotid Revascularization Procedures After Ischemic Stroke.
    Stroke 2016.

  1. Pischke S, Hartl J, Pas SD, Lohse AW, et al.
    Hepatitis E virus infection beyond the liver?
    J Hepatol 2016.

  2. Mazzanti A, Ng K, Faragli A, Maragna R, et al.
    Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    J Am Coll Cardiol 2016;68:2540-2550.

  3. Towfighi A, Ovbiagele B, El Husseini N, Hackett ML, et al.
    Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.
    Stroke 2016.

  4. Schwartz JE, Burg MM, Shimbo D, Broderick JE, et al.
    Clinic Blood Pressure Underestimates Ambulatory Blood Pressure in an Untreated Employer-Based US Population: Results From the Masked Hypertension Study.
    Circulation 2016;134:1794-1807.

  5. Sakr Y, Rubatto Birri PN, Kotfis K, Nanchal R, et al.
    Higher Fluid Balance Increases the Risk of Death From Sepsis: Results From a Large International Audit.
    Crit Care Med 2016.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016